Congresswoman's Insights on Betting in Women's Health Startups and Event Companies

U.S. Representative Kelly Louise Morrison (D-Minnesota, 3rd District) disclosed in April 2026 that she acquired new equity stakes in four privately held companies. The largest transactions reported were a $50,001–$100,000 (approximately KRW 65 million–130 million) purchase of Artistry in Motion, LLC and a $15,001–$50,000 (approximately KRW 20 million–65 million) purchase of Pelvital USA, Inc., both classified as “external private investments.” Notably, on April 22—the same day these trades took place and following mounting controversy over her stock and private‐equity holdings—Morrison announced she would divest all her individual stock and private‐equity interests.

Artistry in Motion, founded in 1994 and based in Los Angeles, is a niche player in the live-events industry, supplying special confetti, streamers, and related equipment to sports venues, concerts, and TV and film productions. Pelvital USA, headquartered in Minneapolis, Minnesota, is a women’s health medical‐device startup best known for “Flyte,” a home-use intravaginal device for treating stress urinary incontinence. Flyte received FDA 510(k) clearance in 2020 and launched commercially in 2021. Given Morrison’s background as an obstetrician-gynecologist and her service on the House Small Business Committee and the Veterans’ Affairs Committee (including its Health Subcommittee), observers view these investments as thematic private‐equity plays aligned with her policy domains in women’s health devices and event/manufacturing industries.

Neither company is publicly traded, so there is no market price or capitalization available. Pelvital’s valuation, however, is heavily influenced by growth in the women’s urinary-incontinence market and shifts in regulatory and insurance environments. Flyte’s market expansion has been underpinned by large-scale clinical trials and FDA approval, and the company is currently negotiating with the Centers for Medicare & Medicaid Services over HCPCS coding and reimbursement levels—an area that remains uncertain. In Artistry in Motion’s case, rising demand for offline events—concerts, sports, and broadcast productions—has bolstered special-effects sales, but revenue could be volatile in the event of an economic slowdown or cuts in entertainment spending, reflecting a relatively aggressive, growth-and-cyclical-sensitive investment profile.

Since taking office, Morrison has reported roughly $5 million in combined public and private stock transactions and has already faced conflict-of-interest scrutiny over her investments in defense and AI companies such as Saronic Technologies. Her stakes in Pelvital and Artistry in Motion similarly raise questions about indirect overlaps with her legislative work on veterans’ medical care, health policy, and small-business support and procurement. While these trades were legally reported under the STOCK Act, renewed bipartisan calls to ban individual stock trading by members of Congress mean that the timing and manner of Morrison’s promised divestments will be a key test of her future ethical and conflict-of-interest risk management.